Response of human colon carcinoma xenografts to recombinant human tumor necrosis factor (TNF).
Osieka
R
R
Department of Medical Oncology, University of Essen.
Glatte
P
P
Niederle
N
N
Schmidt
C G
CG
D000818:Animals; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000628:therapy*; D003561:Cytarabine / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008297:Male; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D011994:Recombinant Proteins; D012673:Semustine / Q000627:therapeutic use; D014183:Transplantation, Heterologous; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use*
D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D003561:Cytarabine; D012673:Semustine; D005472:Fluorouracil